Loading...
. One of Britain’s leading start-ups in the race to develop "living medicines" to treat cancer has raised $80m (£60m) to take its drugs into clinical trials. Autolus, a biotech spun out of University College London three years ago, has attracted backing from prominent fund manager Neil Woodford and specialist health investors Syncona and Arix....
Last updated: Jan 7, 2026